LUCAS (Lucentis Compared to Avastin Study)
clinical trial
Press Enter · cited answer in seconds
0 sources
LUCAS (Lucentis Compared to Avastin Study)
Summary
LUCAS (Lucentis Compared to Avastin Study) is a clinical trial[1].
Key Facts
- LUCAS (Lucentis Compared to Avastin Study) is in the country of Norway[2].
- LUCAS (Lucentis Compared to Avastin Study)'s instance of is recorded as clinical trial[3].
- LUCAS (Lucentis Compared to Avastin Study)'s start time is recorded as +2009-03-31T00:00:00Z[4].
- LUCAS (Lucentis Compared to Avastin Study)'s end time is recorded as +2014-08-31T00:00:00Z[5].
- LUCAS (Lucentis Compared to Avastin Study)'s sponsor is recorded as Oslo University Hospital[6].
- LUCAS (Lucentis Compared to Avastin Study)'s main subject is recorded as macular degeneration[7].
- LUCAS (Lucentis Compared to Avastin Study)'s number of participants is recorded as {'unit': '1', 'amount': '+420'}[8].
- LUCAS (Lucentis Compared to Avastin Study)'s title is recorded as LUCAS. A Randomized, Prospective, Multicenter Study Comparing the Effect of Intravitreal Injection of Bevacizumab to Ranibizumab When Given to Patients With Neovascular Age-related Macular Degeneration[9].
- LUCAS (Lucentis Compared to Avastin Study)'s short name is recorded as LUCAS[10].
- LUCAS (Lucentis Compared to Avastin Study)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[11].
- LUCAS (Lucentis Compared to Avastin Study)'s ClinicalTrials.gov ID is recorded as NCT01127360[12].
- LUCAS (Lucentis Compared to Avastin Study)'s research intervention is recorded as bevacizumab[13].
- LUCAS (Lucentis Compared to Avastin Study)'s research intervention is recorded as ranibizumab[14].
- LUCAS (Lucentis Compared to Avastin Study)'s clinical trial phase is recorded as phase IV clinical trial[15].
- LUCAS (Lucentis Compared to Avastin Study)'s research site is recorded as University of Oslo[16].
- LUCAS (Lucentis Compared to Avastin Study)'s study type is recorded as interventional study[17].